LivaNova Reports First Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
Livanova (LIVN) PT Raised to $99 at Piper Sandler Following Earnings
April 28, 2021 1:33 PM EDTPiper Sandler analyst Adam Maeder raised the price target on Livanova (NASDAQ: LIVN) to $99.00 (from $92.00) while maintaining a Overweight rating.
... MoreLivaNova plc (LIVN) Tops Q1 EPS by 21c, Revenues Beat; Offers FY21 EPS Mid-Point Guidance Above Consensus
April 28, 2021 5:43 AM EDTLivaNova plc (NASDAQ: LIVN) reported Q1 EPS of $0.36, $0.21 better than the analyst estimate of $0.15. Revenue for the quarter came in at $247.6 million versus the consensus estimate of $232.3 million.
Epilepsy sales growth in the quarter reflects improving market dynamics, especially in the United... More
